0 results for 'Takeda'
Chancery Considers Measure of Damages in Case Involving Cancer Therapeutics Company
In most cases, courts are presented with competing experts offering damage valuations based on estimates, forecasts, projections and discounts, and are then tasked with rending this information into a monetary amount sufficient to compensate a party for its injury.Albertsons Snags FIFA's Former Compliance Chief, Ex-DLA Piper Partner
Edward Hanover joined the grocery chain after its general counsel sought his help in building a modern compliance program, which will focus, in part, on a transition to e-commerce.Albertsons Snags FIFA's Former Compliance Chief, Ex-Silicon Valley DLA Piper Partner
California-based Edward Hanover joined the grocery chain after its general counsel sought his help in building a modern compliance program, which will focus, in part, on a transition to e-commerce.Parties' Shower Curtains Not Substantially the Same; Preliminary Injunction Denied
Litigator of the Week Shout Outs and Runners-Up
Featuring big wins from Baker Botts, Aylstock, Witkin, Kreis & Overholtz, Quinn Emanuel, Wilmer, and more.View more book results for the query "Takeda"
The Fallacy of Statistical Significance Under 'Daubert'
An important look at the standard for assessing medical causality, including the Bradford-Hill factors and U.S. Supreme Court precedent.$19M in Contingent Attorneys Fees Ordered in Post-Trial Merger Case
Those fees are included in an over $45 million judgment leveled against Shire U.S. Holdings in a case that took the uncommon path of going to trial while plaintiffs were represented on contingency.Post-Merger Contract Dispute Case Nets Lawyers $19M in Contingent Fees
Those fees are included in an over $45 million judgment leveled against Shire U.S. Holdings in a case that took the uncommon path of going to trial while plaintiffs were represented on contingency.The Actos MDL Is Over, But Drugmakers Face New Litigation
The Reardon Law Firm attorneys filed a federal lawsuit Monday against the makers of the drug Actos, claiming it causes bladder cancer.Linklaters Taps Antitrust Attorney to Lead US Practice
Tom McGrath has been a partner in New York since 2005. He replaces Tom Shropshire, who's taking over as general counsel at Diageo.Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now